Literature DB >> 32386458

Trophoblast-secreted soluble-PD-L1 modulates macrophage polarization and function.

Yong-Hong Zhang1,2, Paulomi Aldo1, Yuan You3, Jiahui Ding3, Janina Kaislasuo1,4, Jesper F Petersen5, Ellen Lokkegaard5, Gang Peng6, Michael J Paidas7, Samantha Simpson1, Lubna Pal1, Seth Guller1, Hong Liu2, Ai Hua Liao2, Gil Mor1,3.   

Abstract

Decidual macrophages are in close contact with trophoblast cells during placenta development, and an appropriate crosstalk between these cellular compartments is crucial for the establishment and maintenance of a healthy pregnancy. During different phases of gestation, macrophages undergo dynamic changes to adjust to the different stages of fetal development. Trophoblast-secreted factors are considered the main modulators responsible for macrophage differentiation and function. However, the phenotype of these macrophages induced by trophoblast-secreted factors and the factors responsible for their polarization has not been elucidated. In this study, we characterized the phenotype and function of human trophoblast-induced macrophages. Using in vitro models, we found that human trophoblast-educated macrophages were CD14+ CD206+ CD86- and presented an unusual transcriptional profile in response to TLR4/LPS activation characterized by the expression of type I IFN-β expression. IFN-β further enhances the constitutive production of soluble programmed cell death ligand 1 (PD-L1) from trophoblast cells. PD-1 blockage inhibited trophoblast-induced macrophage differentiation. Soluble PD-L1 (sPD-L1) was detected in the blood of pregnant women and increased throughout the gestation. Collectively, our data suggest the existence of a regulatory circuit at the maternal fetal interface wherein IFN-β promotes sPD-L1 expression/secretion by trophoblast cells, which can then initiate a PD-L1/PD-1-mediated macrophage polarization toward an M2 phenotype, consequently decreasing inflammation. Macrophages then maintain the expression of sPD-L1 by the trophoblasts through IFN-β production induced through TLR4 ligation. ©2020 Society for Leukocyte Biology.

Entities:  

Keywords:  IFN-β; LPS; PD1; Trophoblast; macrophage; soluble PD-L1

Mesh:

Substances:

Year:  2020        PMID: 32386458      PMCID: PMC8190653          DOI: 10.1002/JLB.1A0420-012RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  82 in total

1.  Phenotypic and functional characteristics of circulating monocytes of elderly persons.

Authors:  H M Sadeghi; J F Schnelle; J K Thoma; P Nishanian; J L Fahey
Journal:  Exp Gerontol       Date:  1999-12       Impact factor: 4.032

2.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

Review 3.  Toll receptors, CD14, and macrophage activation and deactivation by LPS.

Authors:  Marina A Dobrovolskaia; Stefanie N Vogel
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

4.  Macrophages at the fetal-maternal interface express markers of alternative activation and are induced by M-CSF and IL-10.

Authors:  Judit Svensson; Maria C Jenmalm; Andreas Matussek; Robert Geffers; Göran Berg; Jan Ernerudh
Journal:  J Immunol       Date:  2011-09-02       Impact factor: 5.422

5.  Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.

Authors:  Joseph P Kolb; Carolyn R Casella; Shuvasree SenGupta; Paula M Chilton; Thomas C Mitchell
Journal:  Sci Signal       Date:  2014-11-11       Impact factor: 8.192

6.  The role of the PD-1/PD-L1 axis in macrophage differentiation and function during pregnancy.

Authors:  Yonghong Zhang; Lina Ma; Xiaohui Hu; Jinlu Ji; Gil Mor; Aihua Liao
Journal:  Hum Reprod       Date:  2019-01-01       Impact factor: 6.918

7.  Viral infection of human lung macrophages increases PDL1 expression via IFNβ.

Authors:  Karl J Staples; Ben Nicholas; Richard T McKendry; C Mirella Spalluto; Joshua C Wallington; Craig W Bragg; Emily C Robinson; Kirstin Martin; Ratko Djukanović; Tom M A Wilkinson
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

8.  Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancy.

Authors:  Elizabeth Ann L Enninga; Susan M Harrington; Douglas J Creedon; Rodrigo Ruano; Svetomir N Markovic; Haidong Dong; Roxana S Dronca
Journal:  Am J Reprod Immunol       Date:  2017-12-04       Impact factor: 3.886

Review 9.  Macrophage Polarization in Physiological and Pathological Pregnancy.

Authors:  Yongli Yao; Xiang-Hong Xu; Liping Jin
Journal:  Front Immunol       Date:  2019-04-15       Impact factor: 7.561

10.  Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype.

Authors:  Charlotte Gustafsson; Jenny Mjösberg; Andreas Matussek; Robert Geffers; Leif Matthiesen; Göran Berg; Surendra Sharma; Jan Buer; Jan Ernerudh
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

View more
  15 in total

Review 1.  Mechanisms of immune regulation by the placenta: Role of type I interferon and interferon-stimulated genes signaling during pregnancy.

Authors:  Jiahui Ding; Anthony Maxwell; Nicholas Adzibolosu; Anna Hu; Yuan You; Aihua Liao; Gil Mor
Journal:  Immunol Rev       Date:  2022-03-20       Impact factor: 10.983

2.  Specific innate immune cells uptake fetal antigen and display homeostatic phenotypes in the maternal circulation.

Authors:  Marcia Arenas-Hernandez; Roberto Romero; Meyer Gershater; Li Tao; Yi Xu; Valeria Garcia-Flores; Errile Pusod; Derek Miller; Jose Galaz; Kenichiro Motomura; George Schwenkel; Robert Para; Nardhy Gomez-Lopez
Journal:  J Leukoc Biol       Date:  2021-12-10       Impact factor: 6.011

3.  Cytotrophoblasts suppress macrophage-mediated inflammation through a contact-dependent mechanism.

Authors:  Alison J Eastman; Erin N Vrana; Maria T Grimaldo; Amanda D Jones; Lisa M Rogers; Donald J Alcendor; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2020-10-16       Impact factor: 3.886

4.  LncRNA NEAT1 Promotes TLR4 Expression to Regulate Lipopolysaccharide-Induced Trophoblastic Cell Pyroptosis as a Molecular Sponge of miR-302b-3p.

Authors:  Dan Fu; Yun Ju; Chunhui Zhu; Yu Pan; Suhua Zhang
Journal:  Mol Biotechnol       Date:  2022-01-22       Impact factor: 2.695

Review 5.  Cellular immune responses in the pathophysiology of preeclampsia.

Authors:  Derek Miller; Kenichiro Motomura; Jose Galaz; Meyer Gershater; Eun D Lee; Roberto Romero; Nardhy Gomez-Lopez
Journal:  J Leukoc Biol       Date:  2021-04-13       Impact factor: 6.011

6.  Crosstalk Between Trophoblasts and Decidual Immune Cells: The Cornerstone of Maternal-Fetal Immunotolerance.

Authors:  Ling Xu; Yanhong Li; Yifei Sang; Da-Jin Li; Meirong Du
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

7.  Immune Regulation, Maternal Infection, Vaccination, and Pregnancy Outcome.

Authors:  Mercy PrabhuDas; Jeanna M Piper; Patrick Jean-Philippe; Marrah Lachowicz-Scroggins
Journal:  J Womens Health (Larchmt)       Date:  2020-11-24       Impact factor: 2.681

Review 8.  Regulation of the innate immune cells during pregnancy: An immune checkpoint perspective.

Authors:  Wen-Xuan Li; Xiang-Hong Xu; Li-Ping Jin
Journal:  J Cell Mol Med       Date:  2021-10-28       Impact factor: 5.310

Review 9.  Crosstalk Between Trophoblast and Macrophage at the Maternal-Fetal Interface: Current Status and Future Perspectives.

Authors:  Jinli Ding; Yan Zhang; Xiaopeng Cai; Lianghui Diao; Chaogang Yang; Jing Yang
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

10.  TNF-α Regulated Endometrial Stroma Secretome Promotes Trophoblast Invasion.

Authors:  Yuan You; Patrick Stelzl; Dana N Joseph; Paulomi B Aldo; Anthony J Maxwell; Nava Dekel; Aihua Liao; Shannon Whirledge; Gil Mor
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.